Bristol-Myers Squibb (BRM) Ratios
Bristol-Myers Squibb Ratios
DE:BRM's free cash flow for Q3 2026 was $3.84B. For the 2026 fiscal year, DE:BRM's free cash flow was decreased by $-344.00M and operating cash flow was $4.18B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.26 | 1.25 | 1.43 | 1.25 | 1.52 |
| Quick Ratio | 1.14 | 1.15 | 1.31 | 1.14 | 1.43 |
| Cash Ratio | 0.44 | 0.44 | 0.51 | 0.42 | 0.64 |
| Solvency Ratio | 0.15 | 0.01 | 0.27 | 0.25 | 0.24 |
| Operating Cash Flow Ratio | 0.60 | 0.64 | 0.62 | 0.60 | 0.74 |
| Short-Term Operating Cash Flow Coverage | 6.26 | 7.42 | 4.44 | 3.06 | 3.28 |
| Net Current Asset Value | $ -42.14B | $ -46.44B | $ -33.90B | $ -38.43B | $ -40.05B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.52 | 0.55 | 0.44 | 0.42 | 0.42 |
| Debt-to-Equity Ratio | 2.55 | 3.13 | 1.41 | 1.31 | 1.27 |
| Debt-to-Capital Ratio | 0.72 | 0.76 | 0.58 | 0.57 | 0.56 |
| Long-Term Debt-to-Capital Ratio | 0.70 | 0.74 | 0.55 | 0.53 | 0.52 |
| Financial Leverage Ratio | 4.87 | 5.67 | 3.23 | 3.12 | 3.04 |
| Debt Service Coverage Ratio | 3.12 | 0.65 | 4.43 | 3.25 | 3.03 |
| Interest Coverage Ratio | 7.26 | 4.96 | 7.27 | 7.53 | 7.15 |
| Debt to Market Cap | 0.41 | 0.43 | 0.37 | 0.26 | 0.32 |
| Interest Debt Per Share | 24.02 | 26.22 | 20.60 | 19.69 | 21.13 |
| Net Debt to EBITDA | 2.42 | 12.90 | 1.55 | 1.64 | 1.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 71.08% | 56.80% | 56.34% | 57.39% | 57.69% |
| EBIT Margin | 23.28% | -13.32% | 21.34% | 19.38% | 20.33% |
| EBITDA Margin | 31.60% | 6.56% | 43.03% | 41.64% | 43.37% |
| Operating Profit Margin | 28.48% | 20.00% | 18.82% | 20.08% | 20.57% |
| Pretax Profit Margin | 19.35% | -17.35% | 18.75% | 16.71% | 17.46% |
| Net Profit Margin | 14.64% | -18.53% | 17.83% | 13.71% | 15.08% |
| Continuous Operations Profit Margin | 14.64% | -18.49% | 17.86% | 13.75% | 15.12% |
| Net Income Per EBT | 75.62% | 106.79% | 95.08% | 82.03% | 86.37% |
| EBT Per EBIT | 67.97% | -86.76% | 99.62% | 83.19% | 84.88% |
| Return on Assets (ROA) | 7.83% | -9.66% | 8.43% | 6.53% | 6.40% |
| Return on Equity (ROE) | 38.19% | -54.78% | 27.27% | 20.37% | 19.46% |
| Return on Capital Employed (ROCE) | 20.60% | 14.03% | 11.62% | 12.37% | 10.91% |
| Return on Invested Capital (ROIC) | 15.03% | 13.59% | 10.59% | 9.61% | 8.93% |
| Return on Tangible Assets | 14.34% | -18.94% | 17.26% | 16.09% | 15.19% |
| Earnings Yield | 6.41% | -7.80% | 7.56% | 4.13% | 5.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.32 | 3.35 | 2.95 | 3.31 | 3.71 |
| Payables Turnover | 3.90 | 5.79 | 6.03 | 6.47 | 6.65 |
| Inventory Turnover | 5.18 | 8.16 | 7.38 | 8.41 | 9.37 |
| Fixed Asset Turnover | 5.28 | 5.78 | 5.60 | 6.18 | 6.66 |
| Asset Turnover | 0.54 | 0.52 | 0.47 | 0.48 | 0.42 |
| Working Capital Turnover Ratio | 8.05 | 6.23 | 6.04 | 5.50 | 4.12 |
| Cash Conversion Cycle | 86.82 | 90.72 | 112.70 | 97.20 | 82.60 |
| Days of Sales Outstanding | 110.00 | 109.00 | 123.79 | 110.21 | 98.49 |
| Days of Inventory Outstanding | 70.45 | 44.72 | 49.45 | 43.41 | 38.97 |
| Days of Payables Outstanding | 93.63 | 63.00 | 60.54 | 56.41 | 54.85 |
| Operating Cycle | 180.46 | 153.73 | 173.24 | 153.61 | 137.45 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 6.94 | 7.49 | 6.70 | 6.13 | 7.30 |
| Free Cash Flow Per Share | 6.29 | 6.88 | 6.11 | 5.61 | 6.86 |
| Dividend Paid and CapEx Coverage Ratio | 2.23 | 2.49 | 2.33 | 2.27 | 3.02 |
| Capital Expenditure Coverage Ratio | 10.80 | 12.17 | 11.46 | 11.69 | 16.66 |
| Operating Cash Flow Coverage Ratio | 0.30 | 0.30 | 0.33 | 0.32 | 0.36 |
| Operating Cash Flow to Sales Ratio | 0.29 | 0.31 | 0.31 | 0.28 | 0.35 |
| Free Cash Flow Yield | 11.67% | 12.16% | 11.92% | 7.80% | 11.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.59 | -12.81 | 13.23 | 24.22 | 19.80 |
| Price-to-Sales (P/S) Ratio | 2.28 | 2.37 | 2.36 | 3.32 | 2.99 |
| Price-to-Book (P/B) Ratio | 5.96 | 7.02 | 3.61 | 4.93 | 3.85 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.57 | 8.22 | 8.39 | 12.83 | 9.09 |
| Price-to-Operating Cash Flow Ratio | 7.78 | 7.55 | 7.66 | 11.73 | 8.54 |
| Price-to-Earnings Growth (PEG) Ratio | -0.09 | 0.06 | 0.43 | -4.24 | -0.11 |
| Enterprise Value Multiple | 9.65 | 49.08 | 7.03 | 9.62 | 8.45 |
| Enterprise Value | 147.02B | 155.50B | 136.16B | 184.85B | 170.10B |
| EV to EBITDA | 9.65 | 49.08 | 7.03 | 9.62 | 8.45 |
| EV to Sales | 3.05 | 3.22 | 3.03 | 4.00 | 3.67 |
| EV to Free Cash Flow | 11.45 | 11.15 | 10.76 | 15.47 | 11.17 |
| EV to Operating Cash Flow | 10.39 | 10.24 | 9.82 | 14.15 | 10.50 |
| Tangible Book Value Per Share | -10.95 | -14.29 | -9.26 | -12.39 | -12.28 |
| Shareholders’ Equity Per Share | 9.05 | 8.06 | 14.22 | 14.58 | 16.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | -0.07 | 0.05 | 0.18 | 0.13 |
| Revenue Per Share | 23.61 | 23.83 | 21.75 | 21.67 | 20.88 |
| Net Income Per Share | 3.46 | -4.41 | 3.88 | 2.97 | 3.15 |
| Tax Burden | 0.76 | 1.07 | 0.95 | 0.82 | 0.86 |
| Interest Burden | 0.83 | 1.30 | 0.88 | 0.86 | 0.86 |
| Research & Development to Revenue | 0.21 | 0.20 | 0.20 | 0.20 | 0.21 |
| SG&A to Revenue | 0.15 | 0.16 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 2.01 | -1.70 | 1.72 | 2.06 | 2.31 |
Currency in USD